RPF1
gene geneOn this page
Summary
RPF1 (ribosome production factor 1 homolog, HGNC:30350) is a protein-coding gene on chromosome 1p22.3, encoding Ribosome production factor 1 (Q9H9Y2). May be required for ribosome biogenesis. It is a common-essential gene (DepMap: required in 91.5% of cancer cell lines).
Enables RNA binding activity. Predicted to be involved in maturation of 5.8S rRNA and maturation of LSU-rRNA. Located in nucleolus.
Source: NCBI Gene 80135 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 81 total
- Cancer dependency (DepMap): dependent in 91.5% of screened cell lines (common-essential)
- MANE Select transcript:
NM_025065
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30350 |
| Approved symbol | RPF1 |
| Name | ribosome production factor 1 homolog |
| Location | 1p22.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000117133 |
| Ensembl biotype | protein_coding |
| Entrez | 80135 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000370654, ENST00000370656, ENST00000923273, ENST00000923274, ENST00000953136, ENST00000953137
RefSeq mRNA: 1 — MANE Select: NM_025065
NM_025065
CCDS: CCDS695
Canonical transcript exons
ENST00000370654 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000775626 | 84489633 | 84489728 |
| ENSE00000830853 | 84482915 | 84482995 |
| ENSE00001067179 | 84495373 | 84495455 |
| ENSE00001067180 | 84496244 | 84496370 |
| ENSE00001067182 | 84490319 | 84490472 |
| ENSE00001067185 | 84495882 | 84496063 |
| ENSE00001143789 | 84479266 | 84479509 |
| ENSE00001162539 | 84480956 | 84481012 |
| ENSE00001453239 | 84497429 | 84498352 |
Expression profiles
Bgee: expression breadth ubiquitous, 284 present calls, max score 96.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 43.2519 / max 842.0722, expressed in 1815 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 3798 | 43.2519 | 1815 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of sigmoid colon | UBERON:0004993 | 96.53 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 96.51 | gold quality |
| secondary oocyte | CL:0000655 | 96.08 | gold quality |
| colonic mucosa | UBERON:0000317 | 95.62 | gold quality |
| heart right ventricle | UBERON:0002080 | 95.46 | gold quality |
| gluteal muscle | UBERON:0002000 | 95.44 | gold quality |
| oral cavity | UBERON:0000167 | 95.42 | gold quality |
| bronchial epithelial cell | CL:0002328 | 95.26 | gold quality |
| deltoid | UBERON:0001476 | 95.23 | gold quality |
| tibialis anterior | UBERON:0001385 | 94.94 | gold quality |
| cartilage tissue | UBERON:0002418 | 94.89 | gold quality |
| biceps brachii | UBERON:0001507 | 94.86 | gold quality |
| skin of hip | UBERON:0001554 | 94.81 | gold quality |
| triceps brachii | UBERON:0001509 | 94.76 | gold quality |
| adult organism | UBERON:0007023 | 94.76 | gold quality |
| corpus epididymis | UBERON:0004359 | 94.75 | gold quality |
| parotid gland | UBERON:0001831 | 94.50 | gold quality |
| myocardium | UBERON:0002349 | 94.50 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.49 | gold quality |
| upper leg skin | UBERON:0004262 | 94.46 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 94.40 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 94.36 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 94.35 | gold quality |
| superficial temporal artery | UBERON:0001614 | 94.26 | gold quality |
| jejunal mucosa | UBERON:0000399 | 94.21 | gold quality |
| bronchus | UBERON:0002185 | 94.09 | gold quality |
| cauda epididymis | UBERON:0004360 | 94.01 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 93.92 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 93.75 | gold quality |
| quadriceps femoris | UBERON:0001377 | 93.55 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
50 targeting RPF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-4687-3P | 99.48 | 66.41 | 968 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 91.5% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 1)
- Human RPF1 and ESF1 in Pre-rRNA Processing and the Assembly of Pre-Ribosomal Particles: A Functional Study. (PMID:38391939)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rpf1 | ENSDARG00000005738 |
| mus_musculus | Rpf1 | ENSMUSG00000028187 |
| rattus_norvegicus | Rpf1 | ENSRNOG00000015969 |
| drosophila_melanogaster | CG6712 | FBGN0032408 |
| caenorhabditis_elegans | WBGENE00009711 |
Paralogs (1): IMP4 (ENSG00000136718)
Protein
Protein identifiers
Ribosome production factor 1 — Q9H9Y2 (reviewed: Q9H9Y2)
Alternative names: Brix domain-containing protein 5, Ribosome biogenesis protein RPF1
All UniProt accessions (2): Q9H9Y2, X6R7Q1
UniProt curated annotations — full annotation on UniProt →
Function. May be required for ribosome biogenesis.
Subcellular location. Nucleus. Nucleolus.
RefSeq proteins (1): NP_079341* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007109 | Brix | Domain |
| IPR044281 | IMP4/RPF1 | Family |
Pfam: PF04427
UniProt features (7 total): region of interest 2, sequence variant 2, chain 1, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8FKV | ELECTRON MICROSCOPY | 2.47 |
| 8FKT | ELECTRON MICROSCOPY | 2.81 |
| 8FKP | ELECTRON MICROSCOPY | 2.85 |
| 8FKR | ELECTRON MICROSCOPY | 2.89 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H9Y2-F1 | 86.01 | 0.72 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 103 (showing top):
GOBP_RIBOSOME_BIOGENESIS, WANG_LMO4_TARGETS_DN, GOBP_MATURATION_OF_LSU_RRNA, GARY_CD5_TARGETS_DN, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS, GOBP_MATURATION_OF_5_8S_RRNA, ACEVEDO_LIVER_CANCER_UP, chr1p22, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS, GOCC_PRERIBOSOME, GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR, GOCC_NUCLEOLUS, GOCC_RIBONUCLEOPROTEIN_COMPLEX, SCGGAAGY_ELK1_02
GO Biological Process (4): maturation of 5.8S rRNA (GO:0000460), maturation of LSU-rRNA (GO:0000470), rRNA processing (GO:0006364), ribosome biogenesis (GO:0042254)
GO Molecular Function (4): RNA binding (GO:0003723), rRNA primary transcript binding (GO:0042134), protein binding (GO:0005515), rRNA binding (GO:0019843)
GO Cellular Component (3): nucleolus (GO:0005730), preribosome, large subunit precursor (GO:0030687), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| rRNA processing | 2 |
| ribosomal large subunit biogenesis | 1 |
| RNA processing | 1 |
| rRNA metabolic process | 1 |
| ribosome biogenesis | 1 |
| ribonucleoprotein complex biogenesis | 1 |
| nucleic acid binding | 1 |
| rRNA binding | 1 |
| binding | 1 |
| RNA binding | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| preribosome | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1734 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RPF1 | BRIX1 | Q8TDN6 | 575 |
| RPF1 | RPF2 | Q9H7B2 | 557 |
| RPF1 | NIFK | Q9BYG3 | 533 |
| RPF1 | NIP7 | Q9Y221 | 479 |
| RPF1 | SBDS | Q9Y3A5 | 394 |
| RPF1 | WDR74 | Q6RFH5 | 352 |
| RPF1 | WDR12 | Q9GZL7 | 351 |
| RPF1 | BOP1 | Q14137 | 350 |
| RPF1 | EBNA1BP2 | Q99848 | 350 |
| RPF1 | TSR1 | Q2NL82 | 349 |
| RPF1 | NOC2L | Q9Y3T9 | 349 |
| RPF1 | NSA2 | O95478 | 349 |
| RPF1 | DCAF13 | Q9NV06 | 348 |
| RPF1 | MAK16 | Q9BXY0 | 348 |
| RPF1 | RRP15 | Q9Y3B9 | 348 |
IntAct
127 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SART3 | PRPF4 | psi-mi:“MI:0914”(association) | 0.730 |
| KRTAP10-7 | RPF1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| RPL14 | RRP8 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| MECP2 | KPNA3 | psi-mi:“MI:0914”(association) | 0.640 |
| NPM1 | NVL | psi-mi:“MI:0914”(association) | 0.610 |
| NPM1 | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.610 |
| RPL28 | MAGEB2 | psi-mi:“MI:0914”(association) | 0.560 |
| MAGEB10 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF324B | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| RRP8 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| RPL37A | MPHOSPH10 | psi-mi:“MI:0914”(association) | 0.530 |
| MACROH2A2 | PPM1G | psi-mi:“MI:0914”(association) | 0.530 |
| RPL18A | RRP8 | psi-mi:“MI:0914”(association) | 0.530 |
| E4F1 | ZBTB24 | psi-mi:“MI:0914”(association) | 0.530 |
| ZCRB1 | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| RPF1 | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| N | RBM47 | psi-mi:“MI:0914”(association) | 0.530 |
| MECP2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | POLRMT | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (174): KRTAP10-7 (Two-hybrid), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS), KIAA0020 (Co-fractionation), RPF2 (Co-fractionation), RPL5 (Co-fractionation), RPF1 (Synthetic Lethality), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS), RPF1 (Affinity Capture-MS)
ESM2 similar proteins: A0A1D8PNQ6, G1TDB3, J9PAS6, O61749, O74172, P05749, P09132, P0C0T4, P0CX49, P0CX50, P14327, P34264, P37164, P37165, P48588, P49181, P52821, P56628, P62851, P62852, P62853, P79009, Q03409, Q09817, Q3E792, Q3ZBG7, Q4WX89, Q54VN6, Q54VZ4, Q56JX5, Q5B8Y4, Q5RBR1, Q6FPX5, Q6PBI5, Q6Q311, Q75DJ1, Q7SC06, Q8AVP1, Q8ISN9, Q8STD9
Diamond homologs: O13823, O14180, O62518, P53941, P54073, Q0VD01, Q5PQR5, Q5R631, Q5R947, Q5RJS9, Q6BYD9, Q6C804, Q6FNN7, Q6IQU6, Q755T8, Q7TND5, Q8AVP1, Q8VHZ7, Q96G21, Q9H9Y2, Q9VKB4, Q9YC08, P38805, Q975H1, Q5JDM5
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 119 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Peptide chain elongation | 18 | 31.7× | 7e-21 |
| Viral mRNA Translation | 18 | 31.7× | 7e-21 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 18 | 31.4× | 7e-21 |
| Selenocysteine synthesis | 18 | 30.1× | 8e-21 |
| Eukaryotic Translation Termination | 18 | 30.1× | 8e-21 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 18 | 29.4× | 9e-21 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | 18 | 29.4× | 9e-21 |
| Formation of a pool of free 40S subunits | 18 | 28.0× | 2e-20 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cytoplasmic translation | 18 | 31.1× | 9e-20 |
| ribosomal large subunit biogenesis | 5 | 20.7× | 2e-04 |
| translation | 19 | 18.2× | 1e-16 |
| ribosomal small subunit biogenesis | 7 | 14.9× | 5e-05 |
| rRNA processing | 10 | 13.2× | 6e-07 |
| regulation of alternative mRNA splicing, via spliceosome | 5 | 11.4× | 3e-03 |
| nucleosome assembly | 8 | 10.5× | 7e-05 |
| RNA processing | 5 | 10.2× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 61 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
824 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:84479360:G:GT | donor_gain | 1.0000 |
| 1:84479505:GGAAG:G | donor_gain | 1.0000 |
| 1:84479506:GAAG:G | donor_gain | 1.0000 |
| 1:84479506:GAAGG:G | donor_gain | 1.0000 |
| 1:84479507:A:T | donor_gain | 1.0000 |
| 1:84479508:AGGT:A | donor_loss | 1.0000 |
| 1:84479509:GGT:G | donor_loss | 1.0000 |
| 1:84479510:G:GA | donor_loss | 1.0000 |
| 1:84479510:G:GG | donor_gain | 1.0000 |
| 1:84480946:A:AG | acceptor_gain | 1.0000 |
| 1:84480947:A:G | acceptor_gain | 1.0000 |
| 1:84480948:C:G | acceptor_gain | 1.0000 |
| 1:84480951:TTTAG:T | acceptor_loss | 1.0000 |
| 1:84480952:TTAGG:T | acceptor_loss | 1.0000 |
| 1:84480954:A:AG | acceptor_gain | 1.0000 |
| 1:84480955:G:GG | acceptor_gain | 1.0000 |
| 1:84480955:GGAAA:G | acceptor_gain | 1.0000 |
| 1:84481008:ATAAG:A | donor_loss | 1.0000 |
| 1:84481009:TAAGG:T | donor_loss | 1.0000 |
| 1:84481010:AAG:A | donor_loss | 1.0000 |
| 1:84481011:AGGTA:A | donor_loss | 1.0000 |
| 1:84481012:GGTAA:G | donor_loss | 1.0000 |
| 1:84481013:GTA:G | donor_loss | 1.0000 |
| 1:84481014:T:A | donor_loss | 1.0000 |
| 1:84482909:A:AG | acceptor_gain | 1.0000 |
| 1:84482910:C:G | acceptor_gain | 1.0000 |
| 1:84482910:CTTA:C | acceptor_loss | 1.0000 |
| 1:84482913:A:AG | acceptor_gain | 1.0000 |
| 1:84482913:AG:A | acceptor_gain | 1.0000 |
| 1:84482913:AGGC:A | acceptor_loss | 1.0000 |
AlphaMissense
2308 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:84490380:G:C | R175T | 1.000 |
| 1:84490381:A:C | R175S | 1.000 |
| 1:84490381:A:T | R175S | 1.000 |
| 1:84489700:T:C | L145P | 0.999 |
| 1:84489706:C:A | T147K | 0.999 |
| 1:84489706:C:G | T147R | 0.999 |
| 1:84490344:T:C | L163P | 0.999 |
| 1:84490380:G:T | R175I | 0.999 |
| 1:84490417:C:G | C187W | 0.999 |
| 1:84490440:T:C | L195P | 0.999 |
| 1:84490446:T:A | V197D | 0.999 |
| 1:84495411:G:C | A219P | 0.999 |
| 1:84495412:C:A | A219D | 0.999 |
| 1:84495948:G:C | G256R | 0.999 |
| 1:84495949:G:A | G256D | 0.999 |
| 1:84495949:G:T | G256V | 0.999 |
| 1:84495964:G:C | R261P | 0.999 |
| 1:84496026:C:G | H282D | 0.999 |
| 1:84496036:G:C | R285P | 0.999 |
| 1:84496038:G:C | D286H | 0.999 |
| 1:84496039:A:T | D286V | 0.999 |
| 1:84496045:T:A | I288K | 0.999 |
| 1:84496047:T:C | F289L | 0.999 |
| 1:84496049:C:A | F289L | 0.999 |
| 1:84496049:C:G | F289L | 0.999 |
| 1:84496054:G:C | R291T | 0.999 |
| 1:84496054:G:T | R291I | 0.999 |
| 1:84496055:A:C | R291S | 0.999 |
| 1:84496055:A:T | R291S | 0.999 |
| 1:84496059:C:G | H293D | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000046271 (1:84485183 C>A), RS1000510086 (1:84486625 G>A,T), RS1000831980 (1:84484874 A>G,T), RS1000873203 (1:84491871 C>T), RS1001191318 (1:84480782 A>C), RS1001318136 (1:84492883 T>C), RS1001387824 (1:84491305 T>C,G), RS1001402832 (1:84483610 A>G), RS1001596052 (1:84478086 A>G), RS1001603840 (1:84493291 A>T), RS1001717874 (1:84486494 A>C,T), RS1001735422 (1:84479757 C>G), RS1002048540 (1:84487989 A>G), RS1002429816 (1:84494239 G>A), RS1002483828 (1:84481243 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| deoxynivalenol | increases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| cylindrospermopsin | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylstilbestrol | increases expression | 1 |
| Endosulfan | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Ribonucleotides | affects binding | 1 |
| Valproic Acid | affects expression | 1 |
| Aflatoxin B1 | affects cotreatment, decreases expression | 1 |
| beta-Naphthoflavone | affects cotreatment, decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3G7 | Abcam HEK293T RPF1 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.